Endovascular Superficial Femoral Artery Treatment: Can it Be as Good as Bypass?

Care of the vascular patient has changed drastically during the last decade, with the introduction of endovascular therapies. Medical management and open surgical bypass have been the traditional options for superficial femoral artery (SFA) occlusive disease. Endovascular revascularization of the SF...

Full description

Saved in:
Bibliographic Details
Published in:Seminars in vascular surgery 2008-12, Vol.21 (4), p.186-194
Main Authors: Schmieder, Gregory C., MD, Panneton, Jean M., MD
Format: Article
Language:English
Subjects:
Amputation
Angioplasty
Arterial Occlusive Diseases - physiopathology
Arterial Occlusive Diseases - surgery
Atherectomy
Constriction, Pathologic
Cryotherapy
Femoral Artery - physiopathology
Femoral Artery - surgery
Humans
Laser Therapy
Minimally Invasive Surgical Procedures
Outcome and Process Assessment (Health Care)
Quality Indicators, Health Care
Recovery of Function
Recurrence
Reoperation
Stents
Surgery
Treatment Outcome
Vascular Patency
Vascular Surgical Procedures - adverse effects
Vascular Surgical Procedures - instrumentation
Vascular Surgical Procedures - standards
Wound Healing
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Care of the vascular patient has changed drastically during the last decade, with the introduction of endovascular therapies. Medical management and open surgical bypass have been the traditional options for superficial femoral artery (SFA) occlusive disease. Endovascular revascularization of the SFA, however, has been increasingly utilized during the past decade. Results of endovascular interventions for SFA stenoses and/or occlusions have been mixed. In addition, several different techniques have been developed to address similar lesions. This added complexity makes it difficult to compare endovascular therapies to surgical bypass. This review will discuss the difficulties in comparing open and endovascular therapies as well as outcomes of endovascular therapies. Finally, the role of endovascular interventions for SFA lesions in the future will be discussed.
ISSN:0895-7967
1558-4518
DOI:10.1053/j.semvascsurg.2008.11.004